218 related articles for article (PubMed ID: 9167046)
1. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic heterogeneity in osteosarcomas.
Hasegawa T; Hirose T; Kudo E; Hizawa K; Usui M; Ishii S
Hum Pathol; 1991 Jun; 22(6):583-90. PubMed ID: 1864588
[TBL] [Abstract][Full Text] [Related]
4. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.
Deckard-Janatpour K; Kragel S; Teplitz RL; Min BH; Gumerlock PH; Frey CF; Ruebner BH
Arch Pathol Lab Med; 1998 Mar; 122(3):266-72. PubMed ID: 9823867
[TBL] [Abstract][Full Text] [Related]
5. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: a study on the nature of stromal and giant cells, and their interrelations.
Hasegawa T; Hirose T; Seki K; Sano T; Hizawa K
J Pathol; 1993 Jul; 170(3):305-10. PubMed ID: 7907656
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
8. Matrix vesicles in bone tumors. Ultrastructural analysis and their significance in neoplastic bone formation.
Yoshida H; Miyazaki S; Yumoto T
Acta Pathol Jpn; 1991 Aug; 41(8):610-7. PubMed ID: 1661059
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas.
Lukás Z; Dvorák K; Kroupová I; Valásková I; Habanec B
Pancreas; 2006 Apr; 32(3):325-9. PubMed ID: 16628090
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma with epithelioid features. An immunohistochemical study.
Hasegawa T; Shibata T; Hirose T; Seki K; Hizawa K
Arch Pathol Lab Med; 1993 Mar; 117(3):295-8. PubMed ID: 7680195
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors.
Meis-Kindblom JM; Kjellström C; Kindblom LG
Semin Diagn Pathol; 1998 May; 15(2):133-43. PubMed ID: 9606804
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopy of bone tumors--osteosarcoma, chondrosarcoma, giant cell tumor of bone.
Komiya S
Nihon Seikeigeka Gakkai Zasshi; 1982 Jul; 56(7):635-57. PubMed ID: 6960100
[TBL] [Abstract][Full Text] [Related]
13. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
14. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.
Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A
Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600
[TBL] [Abstract][Full Text] [Related]
15. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
16. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
17. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
19. New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations.
Roessner A; Mellin W; Hiddemann W; Voss B; Vollmer E; Grundmann E
Semin Diagn Pathol; 1984 Aug; 1(3):199-214. PubMed ID: 6600111
[TBL] [Abstract][Full Text] [Related]
20. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
Park YK; Yang MH; Kim YW; Park HR
J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
